RAMP3 antibody
Principal name
RAMP3 antibody
Alternative names for RAMP3 antibody
CRLR activity-modifying protein 3, Receptor activity-modifying protein 3, Calcitonin-receptor-like receptor activity-modifying protein 3
Ncbi ID
9606, NP_005847.1, NP_005847, NP_062384.1, NM_019511, NM_020100, NM_005856
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection))
Background of RAMP3 antibody
- Kit Component:
- - KN314452G1, Ramp3 gRNA vector 1 in pCas-Guide vector
- KN314452G2, Ramp3 gRNA vector 2 in pCas-Guide vector
- KN314452D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Kuwasako K. et al. (2008) Biochem Biophys Res Commun. 377:109-113.Roh J. et al. (2004) J Biol Chem. 279:7264-7274
Detection limit for recombinant GST tagged RAMP3 is approximately 0.03ng/ml as a capture antibody.
Breast: Formalin-Fixed Paraffin Embedded (FFPE)
Western Blot analysis of RAMP3 expression in transfected 293T cell line (H00010268-T01) by RAMP3 MaxPab polyclonal antibody.Lane 1: RAMP3 transfected lysate(16.50 KDa).Lane 2: Non-transfected lysate.
Western blot analysis of RAMP3 Antibody Cat.-AP53574PU-N in Mouse kidney tissue lysates (35ug/lane). This demonstrates the RAMP3 antibody detected the RAMP3 protein (arrow).
Western blot analysis of RAMP3 Antibody Cat.-AP53574PU-N in NCI-H292 cell line lysates (35ug/lane). This demonstrates the RAMP3 antibody detected the RAMP3 protein (arrow).
Predicted cell location: Cytoplasm. Positive control: Human ovarian and thyroid cancer tissue . Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded human ovarian cancer tissue using RAMP3 antibody at dilution 1/40, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human ovarian and thyroid cancer tissue . Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using RAMP3 antibody at dilution 1/40, on the right is treated with the fusion protein. (Original magnification:x200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA322549 | RAMP3 antibody |
||||||
| Anti-RAMP3 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| AP08315PU-N | RAMP3 (N-term) antibody |
||||||
 |
Rabbit | IgG | Aff - Purified | Hu | E, P, WB |
50 µg /
€425.00
|
|
| OriGene Technologies GmbH | |||||||
| AP53574PU-N | RAMP3 (C-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu, Ms | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| +1 additional image |
|||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR201003L2V | Lenti ORF particles, Ramp3 (GFP-tagged) - Mouse receptor (calcitonin) activity modifying protein 3 (Ramp3), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR201003L1V | Lenti ORF particles, Ramp3 (Myc-DDK-tagged) - Mouse receptor (calcitonin) activity modifying protein 3 (Ramp3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR204252L2V | Lenti ORF particles, Ramp3 (GFP-tagged ORF) - Rat receptor (G protein-coupled) activity modifying protein 3 (Ramp3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR204252L1V | Lenti ORF particles, Ramp3 (Myc-DDK-tagged ORF) - Rat receptor (G protein-coupled) activity modifying protein 3 (Ramp3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
